HIV Clinical Research Unit
into investigational pharmaceutical therapies. At the HIV Clinical Research Unit, we create these opportunities for our patients every day. Synergistically combining our efforts with state of the art clinical facilities for HIV primary care at the Specialty Care Center (which even includes a dental care program) our patients receive the highest quality care possible. 
ices, and outcomes research. For the past 13 years, the physicians and staff of the USF Division of Infectious Disease have been involved in bringing 24 HIV medications to market, including nucleoside/nucleotide reverse transcriptase inhibitors, non-nucleoside/non-nucleotide reverse transcriptase inhibitors, protease inhibitors, entry inhibitors, and integrase inhibitors. We accept unfunded patients, Medicare, Medicaid, Hillsborough Heathcare and many commercial plans.
